Review: A Single-Pill Combination of Telmisartan plus Amlodipine for the Treatment of Hypertension

References

• . Chobanian AV, Bakris GL, Black HR, ; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA. 2003; 289(19):2560–2572
   PubMed Web of Science ®Google Scholar
• . Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002; 360(9349):1903–1913
   PubMed Web of Science ®Google Scholar
• . Cheung BM, Ong KL, Man YB, Lam KS, Lau CP. Prevalence, awareness, treatment, and control of hypertension: United States National Health and Nutrition Examination Survey 2001–2002. J Clin Hypertens (Greenwich). 2006; 8(2):93–98
   PubMedGoogle Scholar
• . Ong KL, Cheung BM, Man YB, Lau CP, Lam KS. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999–2004. Hypertension. 2007; 49(1):69–75
   PubMed Web of Science ®Google Scholar
• . Fang J, Alderman MH, Keenan NL, Ayala C, Croft JB. Hypertension control at physicians' offices in the United States. Am J Hypertens. 2008; 21(2):136–142
   PubMed Web of Science ®Google Scholar
• . Wang YR, Alexander GC, Stafford RS. Outpatient hypertension treatment, treatment intensification, and control in Western Europe and the United States. Arch Intern Med. 2007; 167(2):141–147
   PubMedGoogle Scholar
• . Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988–2008. JAMA. 2010; 303(20):2043–2050
   PubMed Web of Science ®Google Scholar
• . Tedesco MA, Natale F, Calabrò R. Effects of monotherapy and combination therapy on blood pressure control and target organ damage: A randomized prospective intervention study in a large population of hypertensive patients. J Clin Hypertens (Greenwich). 2006; 8(9):634–641
   PubMedGoogle Scholar
• . Epstein M, Bakris G. Newer approaches to antihypertensive therapy. Use of fixed-dose combination therapy. Arch Intern Med. 1996; 156(17):1969–1978
   PubMedGoogle Scholar
• . Smith DH. Fixed-dose combination antihypertensives and reduction in target organ damage: Are they all the same? Am J Cardiovasc Drugs. 2007; 7(6):413–422
   PubMed Web of Science ®Google Scholar
• . Allemann Y, Fraile B, Lambert M, Barbier M, Ferber P, Izzo JL Jr. Efficacy of the combination of amlodipine and valsartan in patients with hypertension uncontrolled with previous monotherapy: The Exforge in Failure after Single Therapy (EX-FAST) study. J Clin Hypertens (Greenwich). 2008; 10(3):185–194
   PubMed Web of Science ®Google Scholar
• . Chrysant SG, Melino M, Karki S, Lee J, Heyrman R. The combination of olmesartan medoxomil and amlodipine besylate in controlling high blood pressure: COACH, a randomized, double-blind, placebo-controlled, 8-week factorial efficacy and safety study. Clin Ther. 2008; 30(4):587–604
   PubMed Web of Science ®Google Scholar
• . Fogari R, Derosa G, Zoppi A, . Effect of telmisartan-amlodipine combination at different doses on urinary albumin excretion in hypertensive diabetic patients with microalbuminuria. Am J Hypertens. 2007; 20(4):417–422
   PubMed Web of Science ®Google Scholar
• . Fogari R, Zoppi A, Derosa G, . Effect of valsartan addition to amlodipine on ankle oedema and subcutaneous tissue pressure in hypertensive patients. J Hum Hypertens. 2007; 21(3):220–224
   PubMed Web of Science ®Google Scholar
• . Littlejohn TW 3rd, Majul CR, Olvera R, ; Study Investigators. Results of treatment with telmisartan-amlodipine in hypertensive patients. J Clin Hypertens (Greenwich). 2009; 11(4):207–213
   PubMed Web of Science ®Google Scholar
• . Littlejohn TW 3rd, Majul CR, Olvera R, . Telmisartan plus amlodipine in patients with moderate or severe hypertension: Results from a subgroup analysis of a randomized, placebo-controlled, parallel-group, 4 × 4 factorial study. Postgrad Med. 2009; 121(2): 5–14
   PubMed Web of Science ®Google Scholar
• . Philipp T, Smith TR, Glazer R, . Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension. Clin Ther. 2007; 29(4):563–580
   PubMed Web of Science ®Google Scholar
• . Poldermans D, Glazes R, Kargiannis S, . Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension. Clin Ther. 2007; 29(2): 279–289
   PubMed Web of Science ®Google Scholar
• . Volpe M, Brommer P, Haag U, Miele C. Efficacy and tolerability of olmesartan medoxomil combined with amlodipine in patients with moderate to severe hypertension after amlodipine monotherapy: A randomized, double-blind, parallel-group, multicentre study. Clin Drug Investig. 2009; 29(1):11–25
   PubMed Web of Science ®Google Scholar
• . Weir MR. Targeting mechanisms of hypertensive vascular disease with dual calcium channel and renin-angiotensin system blockade. J Hum Hypertens. 2007; 21(10):770–779
   PubMedGoogle Scholar
• . Twynsta (telmisartan/amlodipine) tablets [package insert]. Ridgefield, CT: Boehringer Ingelheim Pharmaceuticals, Inc; 2010
   Google Scholar
• . Micardis (telmisartan) tablets [package insert]. Ridgefield, CT: Boehringer Ingelheim Pharmaceuticals, Inc; 2009
   Google Scholar
• . Zhu JR, Bai J, Cai NS, . Efficacy and safety of telmisartan vs. losartan in control of mild-to-moderate hypertension: A multicentre, randomised, double-blind study. Int J Clin Pract Suppl. 2004;(145):46–49
   Google Scholar
• . Chen JH, Cheng JJ, Chen CY, . Comparison of the efficacy and tolerability of telmisartan 40 mg vs. enalapril 10 mg in the treatment of mild-to-moderate hypertension: A multicentre, double-blind study in Taiwanese patients. Int J Clin Pract Suppl. 2004;(145):29–34
   Google Scholar
• . Calvo C, Hermida RC, Ayala DE, Ruilope LM. Effects of telmisartan 80 mg and valsartan 160 mg on ambulatory blood pressure in patients with essential hypertension. J Hypertens. 2004; 22(4):837–846
   PubMedGoogle Scholar
• . Manolis AJ, Reid JL, de Zeeuw D, Murphy MB, Seewaldt-Becker E, Köster J; ARAMIS Study Group. Angiotensin II receptor antagonist telmisartan in isolated systolic hypertension (ARAMIS) study: Efficacy and safety of telmisartan 20, 40 or 80 mg versus hydrochlorothiazide 12.5 mg or placebo. J Hypertens. 2004; 22(5):1033–1037
   PubMedGoogle Scholar
• . Smith DH, Matzek KM, Kempthorne-Rawson J. Dose response and safety of telmisartan in patients with mild to moderate hypertension. J Clin Pharmacol. 2000; 40(12 pt 1):1380–1390
   PubMedGoogle Scholar
• . Littlejohn T, Mroczek W, Marbury T, VanderMaelen CP, Dubiel RF. A prospective, randomized, open-label trial comparing telmisartan 80 mg with valsartan 80 mg in patients with mild to moderate hypertension using ambulatory blood pressure monitoring. Can J Cardiol. 2000; 16(9):1123–1132
   PubMedGoogle Scholar
• . Norvasc (amlodipine besylate) tablets [package insert]. New York, NY: Pfizer Inc; 2010
   Google Scholar
• . Frishman WH, Brobyn R, Brown RD, Johnson BF, Reeves RL, Wombolt DG. A randomized placebo-controlled comparison of amlodipine and atenolol in mild to moderate systemic hypertension. J Cardiovasc Pharmacol. 1988; 12( suppl 7):S103–S106
   Google Scholar
• . Johnson BF, Frishman WH, Brobyn R, Brown RD, Reeves RL, Wombolt DG. A randomized, placebo-controlled, double-blind comparison of amlodipine and atenolol in patients with essential hypertension. Am J Hypertens. 1992; 5(10):727–732
   PubMedGoogle Scholar
• . Lorimer AR, Smedsrud T, Walker P, Tyler HM. A comparison of amlodipine, verapamil and placebo in the treatment of mild to moderate hypertension. Amlodipine Study Group. J Hum Hypertens. 1989; 3(3): 191–196
   PubMedGoogle Scholar
• . Neutel J, Mancia G, Black HR, . Single-Pill Combination of Telmisartan 80 mg/Amlodipine 10 mg Provides Superior Blood-Pressure Reductions in Patients with Severe Hypertension: TEAMSTA Severe Hypertension Study. Poster LB-PO-10. Presented at: American Society of Hypertension 2010 Annual Scientific Meeting and Exposition; May 1–4, 2010; New York, NY
   Google Scholar
• . White WB, Littlejohn TW, Majul CR, . Effects of telmisartan and amlodipine in combination on ambulatory blood pressure in stages 1–2 hypertension. Blood Press Monit. 2010; 15(4):205–212
   PubMed Web of Science ®Google Scholar
• . Mancia G, De Backer G, Dominiczak A, ; Management of Arterial Hypertension of the European Society of Hypertension; European Society of Cardiology. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007; 25(6):1105–1187
   PubMed Web of Science ®Google Scholar
• . Ahrens K, Bramlage P. Importance of a fixed combination of telmisartan and amlodipine for the treatment of hypertension. Drugs Today (Barc). 2010; 46(5):339–350
   PubMedGoogle Scholar
• . de la Sierra A. Mitigation of calcium channel blocker-related oedema in hypertension by antagonists of the renin-angiotensin system. J Hum Hypertens. 2009; 23(8):503–511
   PubMedGoogle Scholar
• . Epstein BJ, Roberts ME. Managing peripheral edema in patients with arterial hypertension. Am J Ther. 2009; 16(6):543–553
   PubMedGoogle Scholar